10/16/2026
NexGen Biotech’s NGS portfolio is growing.
We’re excited to introduce four targeted sequencing reagent panels for oncology research:
🧬 Breast Cancer NGS — 16 genes
🧬 Lung Cancer NGS — 24 genes
🧬 Colorectal Cancer NGS — 21 genes
🧬 Hotspot Cancer NGS — 50 genes
Designed to explore selected cancer-associated gene regions through targeted library preparation for Illumina sequencing.
Interested in adding NGS reagents to your laboratory’s research workflow? Message me directly for panel specifications and pricing.
🌐 nxgbiotech.com
For Research Use Only. Not for use in diagnostic procedures.